Search research articles
Contact Us
Filters
Showing results (741-750 of 3,553) with videos related to
Page
of 356
Sort By:
Bioanalysis
|
September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)
Steve Lowes, Mark Boterman, Mira Doig, et al.
Bioanalysis
|
September 28, 2012
Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals
Michael G Tovey, Christophe Lallemand
Bioanalysis
|
September 5, 2012
Could traditional mass-balance studies in the 'twilight zone' be improved by means of accelerator MS measurements?
Leif D Svensson
Bioanalysis
|
September 5, 2012
Applications of accelerator MS in pediatric drug evaluation
L T Vuong, A B Blood, J S Vogel, et al.
Bioanalysis
|
September 5, 2012
Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites
Cong Wei, James E Grace, Tatyana A Zvyaga, et al.
Bioanalysis
|
September 5, 2012
Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management
Yong Huang, Robert Shi, Winnie Gee, et al.
Bioanalysis
|
September 5, 2012
Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications
Fred van Heuveln, Henri Meijering, Jaap Wieling
Bioanalysis
|
August 22, 2012
Protease cleavage lights up nanoparticle
Andreas C Hadjivasiliou
Bioanalysis
|
July 17, 2012
Bioanalysis Young Investigator: Maria Lorna A De Leoz
Maria Lorna A De Leoz
Bioanalysis
|
July 17, 2012
Your bioanalytical data are only as good as your samples
Candice B Kissinger, Peter T Kissinger
Page
of 356
Search research articles
Search
Showing results (741-750 of 3,553) with videos related to
Sort By:
Page
of 356
Bioanalysis
|
September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)
Steve Lowes, Mark Boterman, Mira Doig, et al.
Bioanalysis
|
September 28, 2012
Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals
Michael G Tovey, Christophe Lallemand
Bioanalysis
|
September 5, 2012
Could traditional mass-balance studies in the 'twilight zone' be improved by means of accelerator MS measurements?
Leif D Svensson
Bioanalysis
|
September 5, 2012
Applications of accelerator MS in pediatric drug evaluation
L T Vuong, A B Blood, J S Vogel, et al.
Bioanalysis
|
September 5, 2012
Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites
Cong Wei, James E Grace, Tatyana A Zvyaga, et al.
Bioanalysis
|
September 5, 2012
Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management
Yong Huang, Robert Shi, Winnie Gee, et al.
Bioanalysis
|
September 5, 2012
Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications
Fred van Heuveln, Henri Meijering, Jaap Wieling
Bioanalysis
|
August 22, 2012
Protease cleavage lights up nanoparticle
Andreas C Hadjivasiliou
Bioanalysis
|
July 17, 2012
Bioanalysis Young Investigator: Maria Lorna A De Leoz
Maria Lorna A De Leoz
Bioanalysis
|
July 17, 2012
Your bioanalytical data are only as good as your samples
Candice B Kissinger, Peter T Kissinger
Page
of 356